|
TSGA14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.755460E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.044600E-04 |
| Normal-vs-Stage2 |
1.548200E-01 |
| Normal-vs-Stage3 |
6.369400E-01 |
| Normal-vs-Stage4 |
4.396400E-01 |
| Stage1-vs-Stage2 |
3.809800E-01 |
| Stage1-vs-Stage3 |
1.239750E-02 |
| Stage1-vs-Stage4 |
4.591500E-02 |
| Stage2-vs-Stage3 |
1.306630E-01 |
| Stage2-vs-Stage4 |
1.060760E-01 |
| Stage3-vs-Stage4 |
7.375400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.972300E-04 |
| Normal-vs-AfricanAmerican |
6.802100E-02 |
| Normal-vs-Asian |
4.308200E-01 |
| Caucasian-vs-AfricanAmerican |
8.241600E-01 |
| Caucasian-vs-Asian |
1.012580E-01 |
| AfricanAmerican-vs-Asian |
3.332200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.973900E-04 |
| Normal-vs-Female |
1.919820E-02 |
| Male-vs-Female |
4.298400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.613200E-01 |
| Normal-vs-Extreme_Weight |
4.337200E-03 |
| Normal-vs-Obese |
3.360000E-02 |
| Normal-vs-Extreme_Obese |
4.866000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.571820E-01 |
| Normal_Weight-vs-Obese |
1.547620E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.610800E-01 |
| Extreme_Weight-vs-Obese |
6.616400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.316400E-01 |
| Obese-vs-Extreme_Obese |
3.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.669600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.28569999999317E-05 |
| Normal-vs-Age(61-80Yrs) |
7.384300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.432800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.780400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.727380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.176600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.959200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.920400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.990400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.00879999488069E-08 |
| Normal-VS-Type2 PRCC |
9.581200E-01 |
| Normal-VS-KIRP CIMP |
6.0088000131131E-09 |
| Normal-VS-Unclassified PRCC |
3.049700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.58370000008712E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.95172824755264E-13 |
| Type1 PRCC-VS-Unclassified PRCC |
1.365230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.14090000002953E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.969800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.52040005427534E-09 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.986400E-01 |
| Normal-vs-N1 |
3.970800E-01 |
| Normal-vs-N2 |
4.908600E-01 |
| N0-vs-N1 |
2.134600E-01 |
| N0-vs-N2 |
5.275200E-01 |
| N1-vs-N2 |
9.827200E-01 |
|
|
